Inflammatory Bowel Disease
Biologics linked to lower dementia rate in older patients with IBD
Impaired humoral, upheld cellular responses in patients with IBD after SARS-CoV-2 vaccine
VIDEO: Tremfya safe, efficacious for moderately to severely active Crohn’s
Interactive decision aid fails to best standard education for biologic selection in IBD
Survey results suggest Black patients face greater barriers to IBD treatment
Why I love rheumatology: It’s all about inter-professionalism
This month’s cover story is a roundtable discussing the coordination of care for patients with both ankylosing spondylitis and inflammatory bowel disease, and features commentary from gastroenterologists and rheumatologists, including Miguel Regueiro, MD; Brett Smith, DO; Ashwin N. Ananthakrishnan, MD, MPH, MBBS; Nicole Cotter, MD; Sharon Dudley-Brown, PhD, FNP-BC; and Seyedehsan Navabi, MD. It is a terrific read and reminded me of one of the many reasons that rheumatology is such a terrific specialty — namely, that we have virtually no boundaries.